论文信息 - Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV. - 字舞流文

Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV.

M. Tsai | Jun‐Yu Zhang | Hsin-Yun Sun | Wen‐Chun Liu | Pei‐Ying Wu | Chia-Jui Yang | C. Hung | W. Ko | Sui‐Yuan Chang | N. Lee | Chia-Wen Li | Yen-Hsu Chen | Y. Chuang | Hsiu‐Wen Wang | M. Ho | Chen-Hsiang Lee | H. Tsai | Yu-Lin Lee | Yu-Shan Huang | Tun-Chieh Chen | Yuan-Ti Lee | P. Lu | Chien-Yu Cheng | Shu-Hsing Cheng | Guan-Jhou Chen | Yi-Chieh Lee | Shi-ping Lin | Chia-Yin Hsieh | Chung-Eng Liu | H. Ku | Te-Yu Lin | Chi-Ying Lin | Sung-Hsi Huang | Yi-Ching Su | M. Hsieh | Kuan-Yin Lin | Ning-Chi Wang | Jia-Juen Lin | Yi-Chia Huang | Hsi-Yen Chang | Ling-Ya Chen | Tung-Che Hung | H. Tang | Li-Shin Su | Sui-Feng Chang | Wen‐Chun Liu | S. Cheng